In 2021, two different meta-analyses reached similar conclusions, documenting a significant association between PCOS and chemerin independent of BMI, but with chemerin serum levels tending to be higher in overweight and obese patients [36,37]. The gene discussed is RARRES2; the disease is polycystic ovary syndrome.